Axa’s Impax Laboratories, Inc. IPXL Stock Holding History

Axa’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-31,875	Closed	-$654K	–	1454
2013 Q3	$654K	Hold	31,875	–	–	﹤0.01%	947
2013 Q2	$636K	Buy	+31,875	New	+$566K	﹤0.01%	922

Other funds holding IPXL

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Axa's IPXL Position: Q4 2013 in Review

Axa sold out of Impax Laboratories, Inc. (IPXL) in Q4 2013, closing a stake of 31,875 shares — an estimated $654K sold.

Axa first reported a position in IPXL in Q2 2013 and held it in 2 quarters. The position peaked at $654K in Q3 2013. 166 funds tracked by Wall St. Rank hold IPXL as of Q4 2013.

Axa reported no remaining Impax Laboratories, Inc. position as of Q4 2013 after selling out during the quarter.
Axa sold 31,875 Impax Laboratories, Inc. shares in Q4 2013, an estimated $654K.
Axa first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 2 quarters.
Axa's Impax Laboratories, Inc. position peaked at $654K in Q3 2013.
166 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2013.

Based on Axa's 13F filing for Q4 2013, filed 13 Feb 2014.